Company Index



















AstraZeneca
阿斯特拉捷利康
NEWS

Plant will produce next-generation treatment that can deliver highly potent cancer-killing agents directly to cancer cells through a targeted antibody
May.21 2024 18:21 PM

- In 2023, Chinese innovative pharmaceutical companies achieved a "net export" in drug transactions, with disclosed overseas licensing deals surpassing $45 billion. Despite the financing "winter" in the pharma industry and a slowdown in domestic IPOs, these transactions signify a positive development for Chinese pharma companies, providing crucial cash flow during industry downturns and validating their global participation.
- High-profile deals include Baiji Shenzhou's agreement with Bristol Myers Squibb potentially worth up to $8.4 billion for a dual-antibody ADC project, highlighting the shift towards innovative drugs and international market penetration. Additionally, AstraZeneca's acquisition of Conch Biotech for $1.2 billion marks significant foreign interest in Chinese biotech firms.
- The surge in outbound transactions from China is seen as both an opportunity for cash-strapped Chinese biotech firms to secure funding and a strategic move by global pharmaceutical giants to diversify their portfolios with innovative assets at competitive prices. This trend underscores the growing recognition of Chinese innovation on the global stage but also raises questions about valuation and negotiation power for future deals.
Feb.24 2024 12:24 PM

The British drugmaker is acquiring Gracell Biotechnologies, building on a run of deals in China, mostly licensing agreements rather than purchases
Dec.28 2023 17:11 PM

In the face of efficacy and safety concerns, China becomes the world’s top exporter of coronavirus shots as logistics companies ramp up flights
Jul.14 2021 21:50 PM

hina, Singapore and Japan are providing medical gear, vaccines as the nation’s case figures hit new highs
Jul.9 2021 21:46 PM

One billion vaccine doses administered on Chinese mainland, huge garbage patch reappears on Tibetan Plateau
Jun.22 2021 20:42 PM

China launches crewed spacecraft Shenzhou-12, country’s Covid-19 vaccination reaches more than 900 million doses
Jun.18 2021 20:42 PM

More transmissible variants, low vaccination rates have seen some places feel the heat of the pandemic for the first time
Jun.8 2021 19:34 PM

By offering a helping hand, China is aiming to protect itself from the pandemic, while also trying to mend fences with its neighbor, experts say
May.10 2021 19:49 PM

The scramble to crank out enough shots to inoculate more than 1 billion Chinese involves multiple companies pursuing different strategies and building massive factories
Mar.5 2021 14:08 PM

Cutting-edge toripalimab utilizes a patient’s own immune system to fight cancer
Mar.1 2021 14:23 PM

Although three Covid-19 vaccines have been approved for emergency use in China, no clinical data involving people over the age of 59 have been made public
Feb.23 2021 19:18 PM

With 2 million doses of Sinovac and Pfizer-BioNTech shots on the way, city plans inoculation campaign starting Feb. 26
Feb.19 2021 07:26 AM

First 100,000 shots to commence around Lunar New Year next week with inoculations from BioNTech due in February and AstraZeneca later
Feb.3 2021 05:49 AM

Now that Covid-19 vaccines are winning approval, the hard part will be making billions of doses and shipping and storing them at super-cold temperatures
Dec.14 2020 05:51 AM

The vaccine stopped an average of 70% of participants from falling ill, an early analysis of the data show
Nov.24 2020 14:26 PM

World Economic Forum survey finds 26% of people wouldn’t be inoculated, citing rushed development, though 97% of Chinese would be receptive
Sep.10 2020 05:52 AM

Beijing has offered similar priority access to its vaccine to Pakistan and many other countries in an effort to further reinforce its clout
Aug.31 2020 14:56 PM

Trump administration threatens U.S. ban of ‘untrusted’ Chinese apps; TikTok to set up Irish data center and London global headquarters
Aug.6 2020 19:41 PM

Jan.16 2019 15:21 PM
- Jun 16, 2025 02:54 PM
- Jun 16, 2025 02:53 PM
- Jun 16, 2025 02:52 PM
MOST POPULAR
- 1Cover Story: Why Modi Won’t Play Cowboys and Indians With Trump, Opting Instead for Strategic Autonomy
- 2Chinese Ex-Employee of U.S. Hedge Fund Two Sigma Faces Fraud Charges
- 3Intel Names New China Chief Amid Business Transition and Market Shifts
- 4China Doubles Down on Policy Drive to Boost Service Spending
- 5XPeng Partners With Magna to Build EVs in Europe